Kolexia
Moreau Thibault
Neurologie
Hôpital François Mitterrand
Dijon, France
285 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Sclérose en plaques récurrente-rémittente Sclérose en plaques chronique progressive Neuromyélite optique COVID-19 Maladies neurodégénératives Leucoencéphalopathies Accident vasculaire cérébral

Industries

Novartis
20 collaboration(s)
Dernière en 2023
Biogen
13 collaboration(s)
Dernière en 2023
Edimark
12 collaboration(s)
Dernière en 2022
Sanofi
8 collaboration(s)
Dernière en 2023

Dernières activités

Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
JAMA neurology   12 février 2024
TELECOG-MS: Multicentre Randomized Blinded Controlled Study of Specific Telerehabilitation of Multidomain Cognitive Impairment in Multiple Sclerosis Using Mixed Evaluation and Ecological Validity
Essai Clinique (Celgene)   06 février 2024
RESPONSE: French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort
Essai Clinique (Hospices Civils de Lyon)   25 janvier 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Multiple sclerosis (Houndmills, Basingstoke, England)   21 janvier 2024
STOP-I-SEP: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years
Essai Clinique (CHU Rennes)   23 octobre 2023
Comparison of Two Methods for Estimating MS-Related Mortality: The Excess Mortality vs. the Cause-Specific Frameworks.
Neurology   12 octobre 2023
POLAR: Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion Among Patients With or Without Lesions at the Magnetic Resonance Imaging (Oligoclonal Profile of Tears)
Essai Clinique (Lille Catholic University)   12 septembre 2023
The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers.
Multiple sclerosis and related disorders   07 juillet 2023
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study.
Multiple sclerosis (Houndmills, Basingstoke, England)   15 juin 2023
Neurodegeneration, oxidative stress and lipid metabolism plasma biomarkers to differentiate Parkinson's disease from atypical parkinsonian syndromes.
Revue neurologique   14 juin 2023